Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530

Amyloid pores from pathogenic mutations

Lashuel, H. A., Hartley, D. M., Petre, B. M., Walz, T., & Lansbury, P. T. (2002) · Nature · doi:10.1038/418291a · Cited by 1,307

Nucleated conformational conversion and the replication of conformational information by a prion determinant.

Serio, T., Cashikar, A., Kowal, A., Sawicki, G., Moslehi, J., Serpell, L., Arnsdorf, M., & Lindquist, S. (2000) · Science · doi:10.1126/science.289.5483.1317 · Cited by 988

Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 817

Fibrils Formed in Vitro from α-Synuclein and Two Mutant Forms Linked to Parkinson's Disease are Typical Amyloid

Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786

Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains

Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618

Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease

Harper, J. D., Wong, S. S., Lieber, C. M., & Lansbury, P. T. (1999) · Biochemistry · doi:10.1021/bi9904149 · Cited by 454

Fibrillogenic Oligomers of Human Cystatin C Are Formed by Propagated Domain Swapping

Wahlbom, M., Wang, X., Lindström, V., Carlemalm, E., Jaskólski, M., & GRUBB, A. O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611368200 · Cited by 128

The Role and Therapeutic Targeting of α-, β- and γ-Secretase in Alzheimer's Disease

MacLeod, R., Hillert, E., Cameron, R. T., & Baillie, G. S. (2015) · Future Science OA · doi:10.4155/fso.15.9 · Cited by 136

Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4

Casas, S., Novials, A., Reimann, F. M., Gomis, R., & Gribble, F. M. (2008) · Diabetologia · doi:10.1007/s00125-008-1111-z · Cited by 128

Characterization of Chemical Exchange between Soluble and Aggregated States of β-Amyloid by Solution-State NMR upon Variation of Salt Conditions

Narayanan, S., & Reif, B. (2005) · Biochemistry · doi:10.1021/bi048264b · Cited by 128

Mitochondrial Ca2+ and neurodegeneration

Calí, T., Ottolini, D., & Brini, M. (2012) · Cell Calcium · doi:10.1016/j.ceca.2012.04.015 · Cited by 132

Aluminum-triggered structural modifications and aggregation of β-amyloids

Ricchelli, F., Drago, D., Filippi, B., Tognon, G., & Zatta, P. F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5141-0 · Cited by 128

Amyloid-β fibrillogenesis: Structural insight and therapeutic intervention

Silva, K. D., Shaw, J. E., & McLaurin, J. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.032 · Cited by 133

New ELISAs with high specificity for soluble oligomers of amyloid β‐protein detect natural Aβ oligomers in human brain but not CSF

Yang, T., Hong, S. Y., O’Malley, T. T., Sperling, R. A., Walsh, D. M., & Selkoe, D. J. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.11.005 · Cited by 122

Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains

Esparza, T. J., Wildburger, N. C., Jiang, H., Gangolli, M., Cairns, N. J., Bateman, R. J., & Brody, D. L. (2016) · Scientific Reports · doi:10.1038/srep38187 · Cited by 127

Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases

Choi, M. L., & Gandhi, S. (2018) · FEBS Journal · doi:10.1111/febs.14587 · Cited by 131

P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease

Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N. N., & Kayed, R. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01012-6 · Cited by 130

Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function

Palanikumar, L., Karpauskaite, L., Al‐Sayegh, M., Chehade, I., Alam, M., Hassan, S., Maity, D., Ali, L., Kalmouni, M., Hunashal, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23985-1 · Cited by 126

Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides

Grönwall, C., Jonsson, A., Lindström, S., Gunneriusson, E., Ståhl, S., & Herne, N. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.09.013 · Cited by 127

Antibodies against β‐amyloid reduce aβ oligomers, glycogen synthase kinase‐3β activation and τ phosphorylation in vivo and in vitro

Ma, Q., Lim, G. P., Harris‐White, M. E., Yang, F., Ambegaokar, S. S., Ubeda, O. J., Glabe, C. G., Teter, B., Frautschy, S. A., & Cole, G. M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20734 · Cited by 126

Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases

Breydo, L., & Uversky, V. N. (2011) · Metallomics · doi:10.1039/c1mt00106j · Cited by 129

Microglia-derived extracellular vesicles in Alzheimer’s Disease: A double-edged sword

Trotta, T., Antonietta Panaro, M., Cianciulli, A., Mori, G., Di Benedetto, A., & Porro, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.020 · Cited by 126

A Key Role for Lysine Residues in Amyloid β-Protein Folding, Assembly, and Toxicity

Sinha, S., Lopes, D. H. J., & Bitan, G. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000247 · Cited by 125

Protein misfolding in neurodegenerative diseases

Agorogiannis, E. I., Agorogiannis, G. I., Papadimitriou, A., & Hadjigeorgiou, G. M. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00558.x · Cited by 127

Treatment Strategies Targeting Amyloid -ProteinPreprint

Schenk, D., Basi, G. S., & Pangalos, M. N. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006387 · Cited by 131

Mutual exacerbation of peroxisome proliferator‐activated receptor γ coactivator 1α deregulation and α‐synuclein oligomerization

Eschbach, J., von Einem, B., Müller, K., Bayer, H., Scheffold, A., Morrison, B. E., Rudolph, K. L., Thal, D. R., Witting, A., Weydt, P., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24294 · Cited by 126

Intersheet rearrangement of polypeptides during nucleation of β-sheet aggregates

Petty, S. A., & Decatur, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502804102 · Cited by 126

Immunotherapy for Alzheimer‘s Disease: From Anti-β-Amyloid to Tau-Based Immunization Strategies

Panza, F., Frisardi, V., Solfrizzi, V., Imbimbo, B. P., Logroscino, G., Santamato, A., Greco, A., Seripa, D., & Pilotto, A. (2012) · Immunotherapy · doi:10.2217/imt.11.170 · Cited by 130

Single-domain antibodies recognize selectively small oligomeric forms of amyloid β, prevent Aβ-induced neurotoxicity and inhibit fibril formation

Lafaye, P. J., Achour, I., England, P., Duyckaerts, C. J., & Rougeon, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.008 · Cited by 121

The Effect of Glycosaminoglycans (GAGs) on Amyloid Aggregation and Toxicity

Iannuzzi, C., Irace, G., & Sirangelo, I. (2015) · Molecules · doi:10.3390/molecules20022510 · Cited by 124

Alzheimer’s disease due to loss of function: A new synthesis of the available data

Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 123

Engineered Lysozyme Amyloid Fibril Networks Support Cellular Growth and Spreading

Reynolds, N. P., Charnley, M., Mezzenga, R., & Hartley, P. G. (2014) · Biomacromolecules · doi:10.1021/bm401646x · Cited by 124

Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life

Shankar, G. M., Leissring, M. A., Adame, A., Sun, X., Spooner, E., Masliah, E., Selkoe, D. J., Lemere, C. A., & Walsh, D. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.021 · Cited by 126

Molecular understanding of a potential functional link between antimicrobial and amyloid peptides

Zhang, M., Zhao, J., & Zheng, J. (2014) · Soft Matter · doi:10.1039/c4sm00907j · Cited by 123

Sequestration of Copper from β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents

Wu, W., Lei, P., Liu, Q. R., Hu, J., Gunn, A. P., Chen, M., Rui, Y., Su, X., Xie, Z., Zhao, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804722200 · Cited by 124

Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases

Li, D., & Liu, C. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00603-7 · Cited by 124

Bovine Insulin Filaments Induced by Reducing Disulfide Bonds Show a Different Morphology, Secondary Structure, and Cell Toxicity from Intact Insulin Amyloid Fibrils

Zako, T., Sakono, M., Hashimoto, N., Ihara, M., & Maeda, M. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.12.3957 · Cited by 124

Naturally Occurring Autoantibodies against β-Amyloid: Investigating Their Role in Transgenic Animal andIn VitroModels of Alzheimer's Disease

Dodel, R. C., Balakrishnan, K., Keyvani, K., Deuster, O., Neff, F., Andrei‐Selmer, L., Röskam, S., Stüer, C., Al‐Abed, Y., Noelker, C., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4401-10.2011 · Cited by 129

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?

Costes, S., Langen, R., Gurlo, T., Matveyenko, A. V., & Butler, P. C. (2013) · Diabetes · doi:10.2337/db12-1326 · Cited by 129

Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies

Cascella, R., Bigi, A., Cremades, N., & Cecchi, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04166-9 · Cited by 130

Repurposing Doxycycline for Synucleinopathies: Remodelling of α-Synuclein Oligomers towards Non-Toxic Parallel Beta-Sheet Structured Species

González-Lizárraga, F., Socías, S. B., Ávila, C. L., Torres-Bugeau, C. M., Barbosa, L. R. S., Binolfi, A., Sepúlveda-Díaz, J. E., Del-Bel, E., Fernandez, C. O., Papy-Garcia, D., et al. (2017) · Scientific Reports · doi:10.1038/srep41755 · Cited by 119

Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques

Pensalfini, A., Albay, R., Rasool, S., Wu, J. W., Hatami, A., Arai, H., Margol, L., Milton, S., Poon, W. W., Corrada, M. M., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.011 · Cited by 120

Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta

Jiang, L., Liu, C., Leibly, D. J., Landau, M., Zhao, M., Hughes, M. P., & Eisenberg, D. S. (2013) · eLife · doi:10.7554/elife.00857 · Cited by 120

Monoclonal Antibodies against Aβ42 Fibrils Distinguish Multiple Aggregation State Polymorphisms in Vitro and in Alzheimer Disease Brain

Hatami, A., Albay, R., Monjazeb, S., Milton, S. C. F., & Glabe, C. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594846 · Cited by 123

Structural Characteristics of α-Synuclein Oligomers

Cremades, N., Chen, S. W., & Dobson, C. M. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.010 · Cited by 123

Chiral modulation of amyloid beta fibrillation and cytotoxicity by enantiomeric carbon dots

Malishev, R., Arad, E., Bhunia, S. K., Shaham‐Niv, S., Kolusheva, S., Gazit, E., & Jelinek, R. (2018) · Chemical Communications · doi:10.1039/c8cc03235a · Cited by 125

Alzheimer’s β-peptide oligomer formation at physiologic concentrations

LeVine, H. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.08.014 · Cited by 125

Antibody to DNA detects scrapie but not normal prion protein

Zou, W., Zheng, J., Gray, D. M., Gambetti, P. L., & Chen, S. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307825100 · Cited by 121

The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology

Cárdenas-Aguayo, M. D. C., Gómez-Virgilio, L., DeRosa, S., & Meraz-Ríos, M. A. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500148z · Cited by 120

Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein

Gomes, L. A., Hipp, S. A., Rijal Upadhaya, A., Balakrishnan, K., Ospitalieri, S., Koper, M. J., Largo-Barrientos, P., Uytterhoeven, V., Reichwald, J., Rabe, S., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02053-5 · Cited by 125

The emerging role of peptidyl‐prolyl isomerase chaperones in tau oligomerization, amyloid processing, and Alzheimer's disease

Blair, L. J., Baker, J. D., Sabbagh, J. J., & Dickey, C. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13033 · Cited by 120

Membrane‐bound β‐amyloid oligomers are recruited into lipid rafts by a fyn‐dependent mechanism

Williamson, R., Usardi, A., Hanger, D. P., & Anderton, B. H. (2007) · The FASEB Journal · doi:10.1096/fj.07-9766com · Cited by 123

Isoflurane-Induced Apoptosis: A Potential Pathogenic Link Between Delirium and Dementia

Xie, Z., Dong, Y., Maeda, U., Moir, R. D., Inouye, S. K., Culley, D. J., Crosby, G., & Tanzi, R. E. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.12.1300 · Cited by 120

Alzheimer's Disease and the Amyloid β-Protein

Walsh, D. M., & Teplow, D. B. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00012-6 · Cited by 121

α-Mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation

Wang, Y., Xia, Z., Xu, J., Wang, Y., Hou, L., Qiu, Y. L., & Chen, H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.016 · Cited by 119

Protective Effects of Fucoidan on Aβ25–35 and d-Gal-Induced Neurotoxicity in PC12 Cells and d-Gal-Induced Cognitive Dysfunction in Mice

Wei, H., Gao, Z., Zheng, L., Zhang, C., Liu, Z., Yang, Y., Teng, H., Hou, L., Yin, Y., & Zou, X. (2017) · Marine Drugs · doi:10.3390/md15030077 · Cited by 120

APP/Aβ structural diversity and Alzheimer's disease pathogenesis

Roher, A. E., Kokjohn, T. A., Clarke, S. G., Sierks, M. R., Maarouf, C. L., Serrano, G. E., Sabbagh, M., & Beach, T. G. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.007 · Cited by 126

Rosemary species: a review of phytochemicals, bioactivities and industrial applications

Aziz, E., Batool, R., Akhtar, W., Shahzad, T., Malik, A. M., Shah, M. A., Iqbal, S., Rauf, A., Zengin, G., Bouyahya, A., et al. (2021) · South African Journal of Botany · doi:10.1016/j.sajb.2021.09.026 · Cited by 127

Kinetic characterization of amyloid-beta 1–42 aggregation with a multimethodological approach

Bartolini, M., Naldi, M., Fiori, J., Valle, F., Biscarini, F., Nicolau, D. V., & Andrisano, V. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.03.020 · Cited by 123

Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets

Paulsson, J. F., Andersson, A., Westermark, P., & Westermark, G. T. (2006) · Diabetologia · doi:10.1007/s00125-006-0206-7 · Cited by 117

Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice

Sacino, A. N., Brooks, M., Thomas, M. A., McKinney, A. B., McGarvey, N. H., Rutherford, N. J., Ceballos‐Diaz, C., Robertson, J., Golde, T. E., & Giasson, B. I. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1268-0 · Cited by 119

Knockout of the Golgi stacking proteins GRASP55 and GRASP65 impairs Golgi structure and function

Bekier, M. E., Wang, L., Li, J., Huang, H., Tang, D., Zhang, X., & Wang, Y. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-02-0112 · Cited by 113

Amyloid β oligomerization is induced by brain lipid rafts

Kim, S., Yi, J.-S., & Ko, Y. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20978 · Cited by 121

A Generic Mechanism of Emergence of Amyloid Protofilaments from Disordered Oligomeric Aggregates

Auer, S., Meersman, F., Dobson, C. M., & Vendruscolo, M. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000222 · Cited by 118

Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies

Gaikwad, S., Senapati, S., Haque, M. A., & Kayed, R. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13490 · Cited by 117

Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer’s Disease Pathogenesis

Maulik, M., Westaway, D. A., Jhamandas, J. H., & Kar, S. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8337-y · Cited by 121

A neurodegenerative disease mutation that accelerates the clearance of apoptotic cells

Kao, A. W., Eisenhut, R. J., Martens, L. H., Nakamura, A., Huang, A., Bagley, J. A., Zhou, P., de Luis, A., Neukomm, L. J., Cabello, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100650108 · Cited by 116

Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation

Hane, F. T., & Leonenko, Z. (2014) · Biomolecules · doi:10.3390/biom4010101 · Cited by 120

Metal-catalyzed Oxidation of α-Synuclein

Cole, N. B., Murphy, D. D., Lebowitz, J., Noto, L. D., Levine, R. L., & Nussbaum, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409946200 · Cited by 119

The various aggregation states of β-amyloid 1–42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression

Tamagno, E., Bardini, P., Guglielmotto, M., Danni, O., & Tabaton, M. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.01.021 · Cited by 119

Formation of Toxic Aβ(1–40) Fibrils on GM1 Ganglioside-Containing Membranes Mimicking Lipid Rafts: Polymorphisms in Aβ(1–40) Fibrils

Okada, T., Ikeda, K., Wakabayashi, M., Ogawa, M., & Matsuzaki, K. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.072 · Cited by 116

Fibril fragmentation in amyloid assembly and cytotoxicity: When size matters

Xue, W.-F., Hellewell, A. L., Hewitt, E. W., & Radford, S. E. (2010) · Prion · doi:10.4161/pri.4.1.11378 · Cited by 117

Protein aggregation, metals and oxidative stress in neurodegenerative diseases

Tabner, B. J., El-Agnaf, O. M. A., German, M. J., Fullwood, N. J., & Allsop, D. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051082 · Cited by 118

Folding events in the 21-30 region of amyloid β-protein (Aβ) studied in silico

Borreguero, J. M., Urbanc, B., Lazo, N. D., Buldyrev, S. V., Teplow, D. B., & Stanley, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502006102 · Cited by 116

The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity

Cecchi, C., & Stefani, M. (2013) · Biophysical Chemistry · doi:10.1016/j.bpc.2013.06.003 · Cited by 117

Stable and Metastable States of Human Amylin in Solution

Reddy, A. S., Wang, L., Singh, S., Ling, Y. L., Buchanan, L. E., Zanni, M. T., Skinner, J. L., & de Pablo, J. J. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.07.014 · Cited by 118

Molecular Dynamics Simulations of Amyloid β -Peptide (1-42): Tetramer Formation and Membrane Interactions

Brown, A. M., & Bevan, D. R. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.08.001 · Cited by 117

Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy

Zaghi, J., Goldenson, B., Inayathullah, M., Lossinsky, A. S., Masoumi, A., Avagyan, H., Mahanian, M., Bernas, M. J., Weinand, M. E., Rosenthal, M. J., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-008-0481-0 · Cited by 117

LRP1 is a neuronal receptor for α-synuclein uptake and spread

Chen, K., Martens, Y. A., Meneses, A., Ryu, D. H., Lu, W., Raulin, A. C., Li, F., Zhao, J., Chen, Y., Jin, Y., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00560-w · Cited by 115

Role of matrix metalloproteinase-3 in neurodegeneration

Kim, E., & Hwang, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07082.x · Cited by 114

Cystatin C Protects Neuronal Cells from Amyloid-β-induced Toxicity

Tizón, B., Ribé, E. M., Mi, W., Troy, C. M., & Levy, E. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1291 · Cited by 115

Modeling an In-Register, Parallel “Iowa” Aβ Fibril Structure Using Solid-State NMR Data from Labeled Samples with Rosetta

Sgourakis, N. G., Yau, W., & Qiang, W. (2014) · Structure · doi:10.1016/j.str.2014.10.022 · Cited by 115

Nucleated polymerization with secondary pathways. III. Equilibrium behavior and oligomer populations

Cohen, S. I. A., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2011) · The Journal of Chemical Physics · doi:10.1063/1.3608918 · Cited by 113

Amyloid Fibres: Inert End-Stage Aggregates or Key Players in Disease?

Tipping, K. W., van Oosten‐Hawle, P., Hewitt, E. W., & Radford, S. E. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.10.002 · Cited by 117

Aggregation Pathways of the Amyloid β(1–42) Peptide Depend on Its Colloidal Stability and Ordered β-Sheet Stacking

Jiang, D., Rauda, I. E., Han, S., Chen, S., & Zhou, F. (2012) · Langmuir · doi:10.1021/la3021436 · Cited by 117

Mechanisms of amyloid formation revealed by solution NMR

Karamanos, T. K., Kalverda, A. P., Thompson, G. S., & Radford, S. E. (2015) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2015.05.002 · Cited by 119

Understanding the Molecular Basis for the Inhibition of the Alzheimer's Aβ-Peptide Oligomerization by Human Serum Albumin Using Saturation Transfer Difference and Off-Resonance Relaxation NMR Spectroscopy

Milojevic, J., Esposito, V., Das, R., & Melacini, G. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067367+ · Cited by 115

Formation of Toxic Fibrils of Alzheimer’s Amyloid β-Protein-(1–40) by Monosialoganglioside GM1, a Neuronal Membrane Component

Okada, T., Wakabayashi, M., Ikeda, K., & Matsuzaki, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.069 · Cited by 116

Amyloid structure – one but not the same: the many levels of fibrillar polymorphism

Pedersen, J. S., Andersen, C. B., & Otzen, D. E. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07888.x · Cited by 114

Energy landscape of amyloidogenic peptide oligomerization by parallel-tempering molecular dynamics simulation: Significant role of Asn ladder

Tsai, H. G., Reches, M., Tsai, C., Gunasekaran, K., Gazit, E., & Nussinov, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408653102 · Cited by 115

Mallory–Denk-bodies: Lessons from keratin-containing hepatic inclusion bodies

Strnad, P., Zatloukal, K., Stumptner, C., Kulaksiz, H., & Denk, H. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.008 · Cited by 115

Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers

Diomede, L., Cassata, G., Fiordaliso, F., Salio, M., Ami, D., Natalello, A., Doglia, S. M., Luigi, A. D., & Salmona, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.002 · Cited by 114

Drosophila Histone Deacetylase 6 Protects Dopaminergic Neurons against α-Synuclein Toxicity by Promoting Inclusion Formation

Du, G., Liu, X., Chen, X., Song, M. L., Yan, Y., Jiao, R., & Wang, C.-C. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-03-0200 · Cited by 116

Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01

Sinha, S., Du, Z., Maiti, P., Klärner, F., Schrader, T. H., Wang, C., & Bitan, G. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200133x · Cited by 113

Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue

Bruggink, K. A., Jongbloed, W., Biemans, E. A. L. M., Veerhuis, R., Claassen, J. A. H. R., Kuiperij, H. B., & Verbeek, M. M. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.09.014 · Cited by 114

Therapeutic Potential of Baicalein in Alzheimer’s Disease and Parkinson’s Disease

Li, Y., Zhao, J., & Hölscher, C. (2017) · CNS Drugs · doi:10.1007/s40263-017-0451-y · Cited by 114

α‐Synuclein oligomers oppose long‐term potentiation and impair memory through a calcineurin‐dependent mechanism: relevance to human synucleopathic diseases

Martin, Z. S., Neugebauer, V., Dineley, K. T., Kayed, R., Zhang, W., Reese, L. C., & Taglialatela, G. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07576.x · Cited by 114

Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: Autoantibodies to Aβ(25–35) oligomers, S100b and neurotransmitters

Алексеевна, Г. М., Davidova, T. B., Mališauskas, M., Sewell, R. D. E., Voskresenskaya, N. I., Wilhelm, K., Elistratova, E. I., Sherstnev, V. V., & Morozova‐Roche, L. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.03.023 · Cited by 112

Amyloid-β Production: Major Link Between Oxidative Stress and BACE1

Tamagno, E., Guglielmotto, M., Monteleone, D., & Tabaton, M. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9283-6 · Cited by 117

Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidation

Leong, S. L., Pham, C. L. L., Galatis, D., Fodero‐Tavoletti, M. T., Perez, K. A., Hill, A. F., Masters, C. L., Ali, F. E. A., Barnham, K. J., & Cappai, R. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.009 · Cited by 114

β-Amyloid Modulation of Synaptic Transmission and Plasticity

Venkitaramani, D. V., Chin, J., Netzer, W. J., Gouras, G. K., Lesné, S., Malinow, R., & Lombroso, P. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3478-07.2007 · Cited by 118

The Non-Core Regions of Human Lysozyme Amyloid Fibrils Influence Cytotoxicity

Mossuto, M. F., Dhulesia, A., Devlin, G. L., Frare, E., Kumita, J. R., de Laureto, P. P., Dumoulin, M., Fontana, A., Dobson, C. M., & Salvatella, X. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.07.005 · Cited by 115

α-Synuclein Protofibrils Inhibit 26 S Proteasome-mediated Protein Degradation

Zhang, N., Tang, Z., & Liu, C.-W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710560200 · Cited by 116

Cleavage Agents for Soluble Oligomers of Amyloid β Peptides

Suh, J., Yoo, S., Kim, M. G., Jeong, K., Ahn, J. Y., Kim, M., Chae, P. S., Lee, T. Y., Lee, J.-H., Lee, J., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200702399 · Cited by 115

Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice

Kawahara, K., Suenobu, M., Yoshida, A., Koga, K., Hyodo, A., Ohtsuka, H., Kuniyasu, A., Tamamaki, N., Sugimoto, Y., & Nakayama, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.049 · Cited by 113

Amyloid Oligomer Structures and Toxicity

Glabe, C. G. (2009) · The Open Biology Journal · doi:10.2174/1874196700902010222 · Cited by 18

1874-1967/09 2009 Bentham Open Open Access

Structures, A. O., & Glabe, C. G. (2016)

Distinct types of amyloid‐β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease

Madhu, P., & Mukhopadhyay, S. (2021) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30141 · Cited by 53

ChemInform Abstract: Structure of Amyloid Oligomers and Their Mechanisms of Toxicities: Targeting Amyloid Oligomers Using Novel Therapeutic Approaches

Salahuddin, P., Fatima, M. T., Abdelhameed, A. S., Nusrat, S., & Khan, R. H. (2016) · ChemInform · doi:10.1002/chin.201622261 · Cited by 1

Amyloid oligomers

Zako, T. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07567.x · Cited by 2